Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000665777 | SCV000789949 | likely pathogenic | Biotinidase deficiency | 2017-02-28 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000665777 | SCV001211152 | pathogenic | Biotinidase deficiency | 2019-12-11 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant disrupts the C-terminus of the BTD protein. Other variant(s) that disrupt this region (p.Leu498Phefs*13) have been determined to be pathogenic (PMID: 17382128, 29359854, 19728141). This suggests that variants that disrupt this region of the protein are likely to be causative of disease. This variant has not been reported in the literature in individuals with BTD-related conditions. ClinVar contains an entry for this variant (Variation ID: 550894). This variant is present in population databases (rs747548016, ExAC 0.002%). This sequence change results in a premature translational stop signal in the BTD gene (p.Leu362*). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 182 amino acids of the BTD protein. |